Assembly Biosciences Stock Market Outlook
| ASMB Stock | USD 25.39 1.66 6.14% |
About 53% of Assembly Biosciences' investor base is interested to short. The analysis of the overall investor sentiment regarding Assembly Biosciences suggests that many traders are impartial. The current market sentiment, together with Assembly Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Assembly Biosciences stock news signals to limit their universe of possible portfolio assets.
Comfort Level 47
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Assembly Biosciences' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Assembly Biosciences.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Assembly Biosciences is 'Sell'. Macroaxis provides Assembly Biosciences buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ASMB positions.
Execute Assembly Biosciences Advice
The Assembly recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Assembly Biosciences. Macroaxis does not own or have any residual interests in Assembly Biosciences or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Assembly Biosciences' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Sell
Market Performance | Weakest | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Almost mirrors the market | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Assembly Biosciences has a Mean Deviation of 2.84, Standard Deviation of 3.81 and Variance of 14.53Our investment recommendation module complements current analysts and expert consensus on Assembly Biosciences. It analyzes the firm potential to grow using all fundamental, technical, and market related data available at the time. To make sure Assembly Biosciences is not overpriced, please confirm all Assembly Biosciences fundamentals, including its price to earning, net income, book value per share, as well as the relationship between the revenue and total debt . Given that Assembly Biosciences has a number of shares shorted of 1.57 M, we suggest you to validate Assembly Biosciences market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Assembly Biosciences Trading Alerts and Improvement Suggestions
| Assembly Biosciences generated a negative expected return over the last 90 days | |
| Assembly Biosciences has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 28.52 M. Net Loss for the year was (40.18 M) with loss before overhead, payroll, taxes, and interest of (24.65 M). | |
| Assembly Biosciences currently holds about 116.69 M in cash with (51.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.41. | |
| Assembly Biosciences has a frail financial position based on the latest SEC disclosures | |
| Roughly 57.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from apnews.com: A top Democrat wants to know if California laws are working. Lawmakers get to pick which ones |
Assembly Biosciences Returns Distribution Density
The distribution of Assembly Biosciences' historical returns is an attempt to chart the uncertainty of Assembly Biosciences' future price movements. The chart of the probability distribution of Assembly Biosciences daily returns describes the distribution of returns around its average expected value. We use Assembly Biosciences price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Assembly Biosciences returns is essential to provide solid investment analysis for Assembly Biosciences.
| Mean Return | -0.23 | Value At Risk | -6.65 | Potential Upside | 5.88 | Standard Deviation | 3.81 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Assembly Biosciences historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Assembly Stock Institutional Investors
| Shares | Gsa Capital Partners Llp | 2025-06-30 | 14.8 K | State Street Corp | 2025-06-30 | 14 K | Man Group Plc | 2025-06-30 | 13.2 K | Ubs Group Ag | 2025-06-30 | 2.9 K | Barclays Plc | 2025-06-30 | 2.8 K | Morgan Stanley - Brokerage Accounts | 2025-06-30 | 2.1 K | Bnp Paribas Arbitrage, Sa | 2025-06-30 | 302 | Northwestern Mutual Wealth Management Co | 2025-06-30 | 260 | Tower Research Capital Llc | 2025-06-30 | 250 | Vanguard Group Inc | 2025-06-30 | 253.8 K | B Group, Inc | 2025-06-30 | 189.3 K |
Assembly Biosciences Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | (13.8M) | 6.8M | (32.6M) | 18.5M | 16.7M | 17.5M | |
| Free Cash Flow | (96.5M) | (84.6M) | 22.5M | (51.1M) | (46.0M) | (48.3M) | |
| Depreciation | 466K | 498K | 450K | 129K | 148.4K | 245.0K | |
| Other Non Cash Items | 44.7M | 3.7M | 2.1M | (2.2M) | (2.6M) | (2.4M) | |
| Capital Expenditures | 3.1M | 102K | 255K | 28K | 32.2K | 30.6K | |
| Net Income | (129.9M) | (93.1M) | (61.2M) | (40.2M) | (36.2M) | (38.0M) | |
| End Period Cash Flow | 45.6M | 52.4M | 19.8M | 38.3M | 44.1M | 36.9M | |
| Change To Netincome | 24.3M | 28.8M | 47.4M | 10.1M | 11.6M | 15.8M | |
| Investments | 27.3M | 89.2M | 37.1M | 40.2M | 46.2M | 48.5M |
Assembly Biosciences Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Assembly Biosciences or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Assembly Biosciences' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Assembly stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 1.11 | |
σ | Overall volatility | 3.94 | |
Ir | Information ratio | -0.07 |
Assembly Biosciences Volatility Alert
Assembly Biosciences exhibits very low volatility with skewness of -0.19 and kurtosis of 0.73. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Assembly Biosciences' stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Assembly Biosciences' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Assembly Biosciences Fundamentals Vs Peers
Comparing Assembly Biosciences' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Assembly Biosciences' direct or indirect competition across all of the common fundamentals between Assembly Biosciences and the related equities. This way, we can detect undervalued stocks with similar characteristics as Assembly Biosciences or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Assembly Biosciences' fundamental indicators could also be used in its relative valuation, which is a method of valuing Assembly Biosciences by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Assembly Biosciences to competition |
| Fundamentals | Assembly Biosciences | Peer Average |
| Return On Equity | -0.37 | -0.31 |
| Return On Asset | -0.16 | -0.14 |
| Profit Margin | (1.04) % | (1.27) % |
| Operating Margin | (1.01) % | (5.51) % |
| Current Valuation | 188.4 M | 16.62 B |
| Shares Outstanding | 15.82 M | 571.82 M |
| Shares Owned By Insiders | 32.29 % | 10.09 % |
| Shares Owned By Institutions | 56.61 % | 39.21 % |
| Number Of Shares Shorted | 1.57 M | 4.71 M |
| Price To Earning | (10.58) X | 28.72 X |
| Price To Book | 2.44 X | 9.51 X |
| Price To Sales | 11.50 X | 11.42 X |
| Revenue | 28.52 M | 9.43 B |
| Gross Profit | (24.65 M) | 27.38 B |
| EBITDA | (45.29 M) | 3.9 B |
| Net Income | (40.18 M) | 570.98 M |
| Cash And Equivalents | 116.69 M | 2.7 B |
| Cash Per Share | 2.41 X | 5.01 X |
| Total Debt | 3.09 M | 5.32 B |
| Debt To Equity | 0.04 % | 48.70 % |
| Current Ratio | 8.31 X | 2.16 X |
| Book Value Per Share | 11.55 X | 1.93 K |
| Cash Flow From Operations | (51.12 M) | 971.22 M |
| Short Ratio | 11.10 X | 4.00 X |
| Earnings Per Share | (4.41) X | 3.12 X |
| Target Price | 47.75 | |
| Number Of Employees | 73 | 18.84 K |
| Beta | 1.15 | -0.15 |
| Market Capitalization | 427.85 M | 19.03 B |
| Total Asset | 119.17 M | 29.47 B |
| Retained Earnings | (825.92 M) | 9.33 B |
| Working Capital | 67.7 M | 1.48 B |
| Current Asset | 68.37 M | 9.34 B |
Note: Purchase by Schornstein Alexander of 300000 shares of Assembly Biosciences [view details]
Assembly Biosciences Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Assembly . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 9054.36 | |||
| Daily Balance Of Power | (0.65) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 26.42 | |||
| Day Typical Price | 26.08 | |||
| Price Action Indicator | (1.86) | |||
| Period Momentum Indicator | (1.66) |
About Assembly Biosciences Buy or Sell Advice
When is the right time to buy or sell Assembly Biosciences? Buying financial instruments such as Assembly Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Assembly Biosciences in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Municipals ETFs Thematic Idea Now
Municipals ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Municipals ETFs theme has 159 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Municipals ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Assembly Biosciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Assembly Stock refer to our How to Trade Assembly Stock guide.You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Assembly Biosciences. If investors know Assembly will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Assembly Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.41) | Revenue Per Share | Quarterly Revenue Growth 0.576 | Return On Assets | Return On Equity |
Assembly Biosciences's market price often diverges from its book value, the accounting figure shown on Assembly's balance sheet. Smart investors calculate Assembly Biosciences' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Assembly Biosciences' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Understanding that Assembly Biosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Assembly Biosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. However, Assembly Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.